Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Antibiotics|May 22, 2004
API-mass spectrometry of polyketides. I. A study on the fragmentation of triketide lactonesGary W Ashley, John R Carney
The Journal of Antibiotics|December 8, 2004
API-mass spectrometry of polyketides. II. Fragmentation analysis of 6-deoxyerythronolide B analogsGary W Ashley, John R Carney
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2013
Hydrogel drug delivery system with predictable and tunable drug release and degradation ratesGary W Ashley, Jeff Henise, Ralph Reid, et al.
Bioconjugate Chemistry|January 14, 2015
Biodegradable tetra-PEG hydrogels as carriers for a releasable drug delivery systemJeff Henise, Brian R Hearn, Gary W Ashley, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 18, 2024
Could a Long-Acting Prodrug of SN-38 be Efficacious in Sacituzumab Govitecan-Resistant Tumors?Daniel V Santi, Gary W Ashley, Luc Cabel, et al.
Journal of Medicinal Chemistry|February 3, 2025
Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity PeptidesEric L Schneider, John A Hangasky, Gary W Ashley, et al.
The Journal of Antibiotics|February 10, 2006
Structure elucidation of new ascomycins produced by genetic engineeringJohn R Carney, Gary W Ashley, Robert L Arslanian, et al.
Bioconjugate Chemistry|June 3, 2016
Subcutaneously Administered Self-Cleaving Hydrogel-Octreotide Conjugates Provide Very Long-Acting OctreotideEric L Schneider, Jeff Henise, Ralph Reid, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2019
Species-specific optimization of PEG~SN-38 prodrug pharmacokinetics and antitumor effects in a triple-negative BRCA1-deficient xenograftShaun D Fontaine, Byron Hann, Ralph Reid, et al.
Pageof 4